weight loss shutter2

What’s Going On With Amgen Stock On Friday?

On Friday, Novo Nordisk A/S (NYSE:NVO) released headline results from the REDEFINE 1 Phase 3 trial in the global REDEFINE program.When evaluating the effects of treatment if all people adhered to treatment, people treated with CagriSema achieved a weight loss of 22.7% after 68 weeks compared to a reduction of 11.8% with cagrilintide 2.4 mg, […]

Read More
Recession Shutterstock

Veteran Wall Street Analyst Counters Recession Fears: ‘We Don’t Expect A Hard Landing Of The Economy’

Veteran Wall Street investor Ed Yardeni challenged fears of a U.S. recession on Monday, opposing the prevailing market sentiment that unsettled global equities.“A weak July employment report does not make a recession,” wrote Ed Yardeni, president of Yardeni Research, in a morning note published ahead of the stronger-than-expected ISM Services PMI report. Yardeni argues that […]

Read More